$PRAX is developing medicines for neurological and psychiatric disorders, where clinical readouts can change expectations quickly. Its chart remains in a broad

$PRAX is developing medicines for neurological and psychiatric disorders, where clinical readouts can change expectations quickly. Its chart remains in a broad corrective structure. The broad bearish swing range has broken lower: a rally from $287.93 reached $392.70, then price fell through the pri…